| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Primerjava abobotulin toksina A in incobotulin toksina A pri zdravljenju prekomerno aktivnega sečnega mehurja in vloga živčnega rastnega faktorja kot napovednega dejavnika uspešnosti zdravljenja
Authors:ID Kavčič, Niko (Author)
ID But, Igor (Mentor) More about this mentor... New window
Files:.pdf DOK_Kavcic_Niko_2025.pdf (8,88 MB)
MD5: 167872091250EEBAEAD6F20D33EF8886
 
Language:Slovenian
Work type:Dissertation
Typology:2.08 - Doctoral Dissertation
Organization:MF - Faculty of Medicine
Abstract:NAMEN Preučiti učinkovitost in varnost zdravljenja z injekcijami abobotulintoksinA in incobotulintoksinA pri bolnicah s prekomerno aktivnim sečnim mehurjem in urgentno urinsko inkontinenco ter določiti učinek lokalnega anestetika na jakost bolečine med posegom in vlogo živčnega rastnega faktorja v urinu. METODE Bolnice smo randomizirali v skupino, ki je prejela 300 enot abobotulintoksinA, oziroma 100 enot incobotulintoksinA, ter v skupino, ki je prejela lokalni anestetik oziroma placebo. Spremljali smo jakost bolečine med posegom, število epizod urinske inkontinence, frekvence, nokturije ter rezultate vprašalnikov »Urogenital Distress Inventory score« (UDI-6), »Incontinence Impact Questionnaire« (IIQ-7), in »Incontinence Quality of Life questionnaire« (I-QOL) in izmerili koncentracijo živčnega rastnega faktorja v urinu. REZULTATI Analizirali smo 54 bolnic s povprečno starostjo 66±13 (SD) let. Pri celokupnih rezultatih vprašalnikov, zadovoljstvu z zdravljenjem, izraženosti simptomov in jakosti bolečine statistično značilnih razlik med skupinami nismo ugotovili. Pri petih bolnicah je po posegu prišlo do retence urina. Pogostnost okužb sečil se med skupinami ni signifikantno razlikovala. Vrednosti koncentracije živčnega rastnega faktorja v urinu večinoma niso bile merljive. ZAKLJUČEK Rezultati zdravljenja z injiciranjem abobotulintoksinA oziroma incobotulintoksinA se glede učinkovitosti, zadovoljstva in pogostnosti zapletov med skupinama niso značilno razlikovali. Lokalni anestetik pred posegom ni imel vpliva na jakost bolečine.
Keywords:abobotulintoksinA, incobotulintoksinA, lokalni anestetik, prekomerno aktivni sečni mehur, živčni rastni faktor
Place of publishing:Maribor
Publisher:[N. Kavčič]
Year of publishing:2025
PID:20.500.12556/DKUM-89120 New window
UDC:616.62-08:615.372(043.3)
COBISS.SI-ID:229147651 New window
Publication date in DKUM:19.03.2025
Views:145
Downloads:20
Metadata:XML DC-XML DC-RDF
Categories:MF
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Licensing start date:16.06.2024

Secondary language

Language:English
Title:Comparison of AbobotulinumtoxinA and IncobotulinumtoxinA in the Treatment of Overactive Bladder and the Role of Nerve Growth Factor as a Predictive Factor of Treatment success
Abstract:AIM A prospective clinical study evaluated the efficacy and safety of abobotulinumtoxinA vs. incobotulinumtoxinA intradetrusor injections in women with overactive bladder and urge urinary incontinence. Also, the effect of local anesthesia on the pain level of the procedure and the role of nerve growth factor in urine was evaluated. METHODS Patients were randomized to receive either 300 units abobotulinumtoxinA or 100 units incobotulinumtoxinA and local anesthesia or placebo. Urinary incontinence episodes, frequency, nocturia, pain intensity, values of the Urogenital Distress Inventory (UDI-6) score, Incontinence Impact Questionnaire (IIQ-7), and Incontinence Quality of Life (I-QOL) questionnaire were evaluated. Concentration of urinary nerve growth factor was determined. RESULTS 54 patients with a mean age of 66±13 (SD) years completed the study. Total questionnaire scores, patient satisfaction, urinary symptom frequency and pain level did not show significant differences between the groups. Urinary retention requiring catheterisation was noted in five patients. There was no significant difference in urinary tract infection occurrence. Urinary nerve growth factor concentration was mostly below the detection limit. CONCLUSION AbobotulinumtoxinA vs. incobotulinumtoxinA intradetrusor injections showed comparable results regarding improved clinical outcome, treatment related side effects and patient satisfaction. Local anesthesia before the procedure did not reduce the pain level.
Keywords:abobotulinumtoxinA, incobotulinumtoxinA, local anesthesia, nerve growth factor, overactive bladder


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica